Bioink with cartilage-derived extracellular matrix microfibers enables spatial control of vascular capillary formation in bioprinted constructs.


Journal

Biofabrication
ISSN: 1758-5090
Titre abrégé: Biofabrication
Pays: England
ID NLM: 101521964

Informations de publication

Date de publication:
20 04 2022
Historique:
received: 20 09 2021
accepted: 30 03 2022
pubmed: 31 3 2022
medline: 26 4 2022
entrez: 30 3 2022
Statut: epublish

Résumé

Microvasculature is essential for the exchange of gas and nutrient for most tissues in our body. Some tissue structures such as the meniscus presents spatially confined blood vessels adjacent to non-vascularized regions. In biofabrication, mimicking the spatial distribution of such vascular components is paramount, as capillary ingrowth into non-vascularized tissues can lead to tissue matrix alterations and subsequent pathology. Multi-material three-dimensional (3D) bioprinting strategies have the potential to resolve anisotropic tissue features, although building complex constructs comprising stable vascularized and non-vascularized regions remains a major challenge to date. In this study, we developed endothelial cell-laden pro- and anti-angiogenic bioinks, supplemented with bioactive matrix-derived microfibers (MFs) that were created from type I collagen sponges (col-1) and cartilage decellularized extracellular matrix (CdECM), respectively. Human umbilical vein endothelial cell (HUVEC)-driven capillary networks started to form 2 d after bioprinting. Supplementing cartilage-derived MFs to endothelial-cell laden bioinks reduced the total length of neo-microvessels by 29%, and the number of microvessel junctions by 37% after 14 d, compared to bioinks with pro-angiogenic col-1 MFs. As a proof of concept, the bioinks were bioprinted into an anatomical meniscus shape with a biomimetic vascularized outer and non-vascularized inner region, using a gellan gum microgel suspension bath. These 3D meniscus-like constructs were cultured up to 14 d, with in the outer zone the HUVEC-, mural cell-, and col-1 MF-laden pro-angiogenic bioink, and in the inner zone a meniscus progenitor cell (MPC)- and CdECM MF-laden anti-angiogenic bioink, revealing successful spatial confinement of the nascent vascular network only in the outer zone. Further, to co-facilitate both microvessel formation and MPC-derived matrix formation, we formulated cell culture medium conditions with a temporal switch. Overall, this study provides a new strategy that could be applied to develop zonal biomimetic meniscal constructs. Moreover, the use of ECM-derived MFs to promote or inhibit capillary networks opens new possibilities for the biofabrication of tissues with anisotropic microvascular distribution. These have potential for many applications including

Identifiants

pubmed: 35354130
doi: 10.1088/1758-5090/ac6282
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Margo L Terpstra (ML)

Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands.

Jinyu Li (J)

Division of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka, Japan.

Anneloes Mensinga (A)

Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Mylène de Ruijter (M)

Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands.

Mattie H P van Rijen (MHP)

Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands.

Charalampos Androulidakis (C)

Composites and Nanostructured Materials Lab, Department of Chemical Engineering, University of Patras, Patras, Greece.
Institute of Chemical Engineering Sciences, Foundation for Research and Technology-Greece (FORTH), Patras, Greece.

Costas Galiotis (C)

Composites and Nanostructured Materials Lab, Department of Chemical Engineering, University of Patras, Patras, Greece.
Institute of Chemical Engineering Sciences, Foundation for Research and Technology-Greece (FORTH), Patras, Greece.

Ioannis Papantoniou (I)

Institute of Chemical Engineering Sciences, Foundation for Research and Technology-Greece (FORTH), Patras, Greece.
Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Prometheus the Leuven R&D Translational Division of Skeletal Tissue Engineering, KU Leuven, Leuven, Belgium.

Michiya Matsusaki (M)

Division of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka, Japan.

Jos Malda (J)

Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Riccardo Levato (R)

Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH